Machine Learning Version of Martin-Hopkins Equation Matches Accuracy of Original LDL-C Calculation
Clinical laboratories may soon be able to use a simplified LDL cholesterol calculation
Already a member? Log in here
Author Information
Miriam Bergeret, MSc
Miriam Bergeret, MSc, is Today's Clinical Lab's managing editor. Before joining Today's Clinical Lab, Miriam obtained her MSc in laboratory medicine and pathobiology from the University of Toronto and gained valuable laboratory experience as a flow cytometry specialist at a cancer research center in Toronto, Canada. She went on to study publishing at Toronto Metropolitan University (formerly Ryerson University) and is an active member of the Editors’ Association of Canada and the Council of Science Editors.
Posts by the Author
Clinical Diagnostics InsiderDiagnostic Testing and Emerging TechnologiesTesting Trends-dtetMiriam Bergeret, MSc
CDC Calls Continued Rise in Cases of STIs “Alarming”
Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.
Already a member? Log in here
Clinical Diagnostics InsiderDiagnostic Testing and Emerging TechnologiesSpecial Focus-dtetMiriam Bergeret, MSc
ACMG Statements Highlight Ongoing Concerns around Polygenic Risk Scores
Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.
Already a member? Log in here
Clinical Diagnostics InsiderDiagnostic Testing and Emerging TechnologiesSpecial Focus-dtetMiriam Bergeret, MSc
An AI Invasion: Improving Breast Cancer Biopsies
Researchers report the first-ever routine clinical use of an AI-based tool for breast cancer biopsies in a pathology lab.
Already a member? Log in here
Mitigating Biotin Interference in Lab Tests
Biotin interference can lead to erroneous lab results in certain IVDs, including some troponin tests.
AACC to Host Discussion with Theranos Whistleblowers
Hosted by AACC president Dr. Stephen R. Master, the talk will cover the ethics of lab testing and the role of clinical lab professionals.
Novel Pathogen Reduction Technologies Effectively Treat Whole Blood Products
Researchers are actively developing PRTs for use in whole blood products to target bacteria and viruses, including SARS-CoV-2.
